AIRXPANDERS INC

PALO ALTO, CA · Founded 2005 · Medtech · Defunct

AeroForm, a needle-free tissue expander system for breast reconstruction

Claim this profile

Follows are private to you and power your alerts

Updated · airxpanders.com

Sector
Medtech
Headquarters
PALO ALTO, CA
Founded
2005
Latest Form D
$14.9M, Jun 2016
Total capital
$38.7M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$38.7M
6 Form D · last Jun 2016
124 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
2 pending · first 2016
Rank in peer group#425 of 1112

Capital timeline

20092010201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $38.7M2nd Form D$5.4M3rd Form D$10.3M4th Form D$4.3M
2009201120132015FEDERAL ↑EQUITY ↓Cumulative $38.7M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$14.9M
  • Private capital raisedForm D · SEC · 5th filing$3M
  • Private capital raisedForm D · SEC · 4th filing$4.3M
  • Private capital raisedForm D · SEC · 3rd filing$10.3M
  • Private capital raisedForm D · SEC · 2nd filing$5.4M
  • Private capital raisedForm D · SEC · 1st filing$752K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#425 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Albert ChaDirectorNamed in SEC Form D filings
  • Barry CheskinExecutive Officer, DirectorNamed in SEC Form D filings
  • Brian ClevingerDirectorNamed in SEC Form D filings
  • Brigitte SmithDirectorNamed in SEC Form D filings
  • Chris JonesExecutive Officer, DirectorNamed in SEC Form D filings
  • Dennis CondonDirectorNamed in SEC Form D filings
Show all 13 people
  • Gregory LichtwardtDirectorNamed in SEC Form D filings
  • John LaiExecutive OfficerNamed in SEC Form D filings
  • Kevin EtzkornDirectorNamed in SEC Form D filings
  • Scott DodsonExecutive Officer, DirectorNamed in SEC Form D filings
  • Scott MurcrayExecutive OfficerNamed in SEC Form D filings
  • Tadmor ShalonDirectorNamed in SEC Form D filings
  • Zita PeachDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 4
Show all 4 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .